COLITE ULCEROSA ACUTA SEVERA: RUOLO DEGLI JAK INHIBITORS. UN’OTTIMA META-ANALISI! DA “CLINICAL GASTROENTEROLOGY & HEPATOLOGY”
Effectiveness and safety of JAK inhibitors in acute severe ulcerative colitis: A systematic review and meta-analysis lAnuraag Jena et al. Abstract Background & aims Janus kinase (JAK) inhibitors have been reported to be useful in acute severe ulcerative colitis (ASUC). We performed a systematic review and meta-analysis to assess their effectiveness and safety in ASUC. Methods…

